chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Tingling in extremities; Feeling of heaviness in limbs; Weakness and cramping throughout body; Brain fog; Weakness and cramping throughout body; This is a spontaneous report from a contactable other healthcare professional, the patient. A 35-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN5318) via an unspecified route of administration in the left arm on an unknown date in 2021 (at the age of 35-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included trazodone (MANUFACTURER UNKNOWN) for an unspecified indication, from an unknown date and unknown if ongoing. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL1383) via an unspecified route of administration in the left arm on 14Jan2021 at 09:00 (at the age of 35-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. On 15Apr2021, the patient experienced tingling in extremities, feeling of heaviness in limbs, weakness and cramping throughout body and brain fog. Since the vaccination, the patient had not been tested for COVID-19. The patient underwent lab tests and procedures, which included Electromyography (EMG), Magnetic resonance imaging (MRI) and the results were unknown. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of reported events which included lab tests and referred to vascular. The clinical outcome of event tingling in extremities, feeling of heaviness in limbs, weakness and cramping throughout body and brain fog were not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Pt. received chicken pox vaccine in Rt. thigh 2 weeks ago. Pt. seen today with red 2-3cm area & blisters in center - also 1 blister on ear lobe.
itchiness; slightly sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (itchiness) and PAIN IN EXTREMITY (slightly sore arm) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032M20A) for COVID-19 vaccination.     Previously administered products included for an unreported indication: FLU in 1962. Concurrent medical conditions included High cholesterol since January 2021.    On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Mar-2021, the patient experienced PRURITUS (itchiness) and PAIN IN EXTREMITY (slightly sore arm). At the time of the report, PRURITUS (itchiness) and PAIN IN EXTREMITY (slightly sore arm) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       This case was linked to MODERNATX, INC.-MOD-2021-079118 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 19-May-2021: TCR - no email or fax available for follow up.; Sender's Comments:  MODERNATX, INC.-MOD-2021-079118:
Tingling; Swelling in armpit; Pain in armpit; Soreness of injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PARAESTHESIA (Tingling), PERIPHERAL SWELLING (Swelling in armpit), AXILLARY PAIN (Pain in armpit) and VACCINATION SITE PAIN (Soreness of injection site) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Mar-2021, the patient experienced VACCINATION SITE PARAESTHESIA (Tingling), PERIPHERAL SWELLING (Swelling in armpit), AXILLARY PAIN (Pain in armpit) and VACCINATION SITE PAIN (Soreness of injection site). At the time of the report, VACCINATION SITE PARAESTHESIA (Tingling), PERIPHERAL SWELLING (Swelling in armpit), AXILLARY PAIN (Pain in armpit) and VACCINATION SITE PAIN (Soreness of injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided. Treatment information was not provided.
Roughly 2 months after vaccine started developing paresthesia, falls, and diagnosed with Guillain Barre per lab findings and r/o other possible causes. Treated with supportive care such as breathing treatments.  No steroids or IVIG required.
flu vax given, then 3 days later, started having numbness in lips and teeth began hurting, then numbness progress to side of face. Spoke to family known physicians. advised to take benadryl and used ice packs to calm the swelling in face (right side by eye and lip). Still having swelling and numbness (slight swelling) off and on, on upper lip. At time of vax, arm turned bright red in area.
She woke up with 102.2 fever.  She has had a fever for 4 days now.  Her behavior has changed, even with Advil or Tylenol to keep the fever down, she has been screaming at night and fussy during the day.  She was previously a happy baby who has never been sick.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A 70-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 09Feb2021 as dose 1, single (Lot number: EL9269), in left arm, on 02Mar2021 as dose 2, single (Lot number: EN6202), in right arm, on 07Oct2021 as dose 3 (booster), single (Lot number: 30145BA), in left arm and on 22Jun2022 as dose 4 (booster), single (Lot number: FK6534) at the age of 69 years, in right arm for covid-19 immunisation. The patient's relevant medical history included: "high blood pressure" (unspecified if ongoing); "hypothyroid" (unspecified if ongoing); "RA" (unspecified if ongoing). Concomitant medication(s) included: LEVOTHYROXINE; HYDROXYCHLOROQUINE; METOPROLOL SUCCINATE. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Unknown Results, notes: Treatment of COVID-19. Therapeutic measures were taken as a result of vaccination failure, covid-19.
Projectile vomiting, throwing up bile, severe crying, and lethargic. Continued till 04/04/2016 still no improvement. Got prescribed Zantac 04/05/2016 and threw up 4 times twice at 6:00PM. Twice 7:30PM.
Around 3 PM  on the 19th, began to develop welts on left arm, them spread to right arm, this evening noted more welts below waist to knee, level  right side, left side and buttocks,  not red but raised, irregular and buttock region areas feel warm to the touch.
Sore arm at injection site; Tender and swollen right arm pit; Fatigue; Chills; Body aches; tender and swollen right armpit; Dose number:3; This is a spontaneous report from a non-contactable reporter (consumer). The reporter is the patient.  A 36-year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in the right arm, administration date 03Dec2021 (Lot number: unknown) at the age of 36 years as dose 3 (booster), single for COVID-19 immunisation. Relevant medical history included: "None". Concomitant medications included birth control (unspecified). Vaccination history included: Bnt162b2 (DOSE 1, SINGLE, Lot Number: UNKNOWN, Anatomical site: Right Arm, Route of administration: Unspecified), administration date: 16Apr2021, when the patient was 36 years old, for COVID-19 immunisation and Bnt162b2 (DOSE 2, SINGLE, Lot Number: UNKNOWN, Anatomical site: Right Arm, Route of administration: Unspecified), administration date: 07May2021, when the patient was 36 years old, for COVID-19 immunisation. The following information was reported: IMMUNISATION (non-serious) with onset 03Dec2021, outcome "unknown", described as "Dose number:3"; VACCINATION SITE PAIN (non-serious) with onset 04Dec2021, outcome "recovering", described as "Sore arm at injection site"; AXILLARY PAIN (non-serious) with onset 04Dec2021, outcome "recovering", described as "Tender and swollen right arm pit"; FATIGUE (non-serious) with onset 04Dec2021, outcome "recovering", described as "Fatigue"; CHILLS (non-serious) with onset 04Dec2021, outcome "recovering", described as "Chills"; PAIN (non-serious) with onset 04Dec2021, outcome "recovering", described as "Body aches"; SWELLING (non-serious) with onset 04Dec2021, outcome "recovering", described as "tender and swollen right armpit". Therapeutic measures were not taken as a result of vaccination site pain, axillary pain, fatigue, chills, pain and swelling. Additional Information: The patient had no known allergies. The patient did not receive any other vaccines within four weeks prior to COVID-19 vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
This case was reported by the mother of a consumer and described the occurrence of developmental delay in a 6-month-old male subject who was vaccinated with INFANRIX (GlaxoSmithKline). A physician or other health care professional has not verified this report. Previous vaccination included 1st dose of INFANRIX ().5 ml in the left thigh) given on 7 May 2007. Following this dose of vaccine, the subject experienced developmental delay, high pitched screaming, chest congestion unspecified and low grade fever. Additional vaccines given on 7 May 2007 included Haemophilus influenzae type b vaccine (HIB vaccine (Sanofi Pasteur) and IPV vaccine (Aventis). A second dose of INFANRIX was given on an unspecified date. No reactions were noted following the 2nd dose of INFANRIX. In September 2007, the subject received 3rd dose of INFANRIX and experienced convulsions which started a few days later and stopped approximately three weeks later. The subject's mother felt that the baby must have had brain swelling as a result of the convulsions. The child also experienced developmental delay. The mother feels that the events are due to vaccination. The baby did not receive any further vaccinations after the 3rd series of vaccines (not specified) given in September 2007. For details surround the events following the 1st dose of INFANRIX, refer to case number A0739259A.
about 12 hours after first dose of vaccine developed a headache with chilling.  Could not get warm and headache increased my temp was orally 101.6.   Dizzyness also appeared. Started drinking lots of water , took Ibuprofen 600mg. My whole body started aching, loss of appetite. Did not eat that day. Next day aches where gone temp low grade. Appetite started to reappear. I am scared to get the second shot.
He received first dose of Shingrix 6 days after first covid-19 vaccine.
her arms were extremely sore / terrible soreness, on a scale was an 8/arm pain; This case was reported by a consumer and described the occurrence of pain in arm in a 18-year-old female patient who received Men B NVS (Bexsero) for prophylaxis.   Co-suspect products included meningococcal B recom vaccine + aloh + omv pre-filled syringe device (Bexsero Pre-Filled Syringe Device) injection syringe for prophylaxis and Men ACWY-CRM NVS (Menveo) for prophylaxis.   On an unknown date, the patient received the 1st dose of Bexsero, Bexsero Pre-Filled Syringe Device and the 1st dose of Menveo. On an unknown date, 1 day after receiving Bexsero, Bexsero Pre-Filled Syringe Device and Menveo, the patient experienced pain in arm. On an unknown date, the outcome of the pain in arm was recovered/resolved.   It was unknown if the reporter considered the pain in arm to be related to Bexsero, Bexsero Pre-Filled Syringe Device and Menveo. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Linked case(s) involving the same patient: US2022AMR155112   Additional Information: GSK Receipt Date: 25-OCT-2022 and 30-OCT-2022 Reporter's comment: The case was reported by parent of the patient. The reporter reported that the patient received first dose of Bexsero and Menveo into unknown arm on the same day and then returned 3 weeks later for a second dose of Bexsero. The patient's arms were extremely sore the following day and she was recovered now. The reporter would think arm pain was not unusual, however she said on a scale of 1 to 10 her arms hurt at about an 8 for 2 to 5 days after the first shots given on the same day.  The patient said her soreness was really terrible if she tried to lift her arms higher than shoulder height, like while driving. Additional Supportive Information: This case had been linked with US2022AMR155112, reported by same reporter.; Sender's Comments:  US-GSK-US2022AMR155112:same reporter
Fever, vomiting, irritability, did not eat for 27hours, hospitalized- fluids and blood work.
This spontaneous report as received from a medical assistant refers to a unspecified number of patients. Medical history and concurrent conditions were not reported. On an unknown date the patients were vaccinated with VAQTA. Dose, route, lot number and expiration date were not reported. On an unknown date an unspecified number of patients received improperly stored VAQTA. No adverse symptoms reported. Follow up information was received on 21-AUG-2014. The reported stated that had heard nothing concerning any incorrect storage of vaccines at the facility. This is one of several reports from the same source. Additional information is not expected (cancelled all scheduled correspondance).
Itches and gets bigger; Warm to the touch; Red; Rush size of a quarter, then had a size of half of a dollar, and now is two and a half inches; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Itches and gets bigger), FEELING HOT (Warm to the touch), ERYTHEMA (Red) and RASH (Rush size of a quarter, then had a size of half of a dollar, and now is two and a half inches) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included METOPROLOL TARTRATE, CALCIUM and COLECALCIFEROL (D3) for an unknown indication.    On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Jan-2021, the patient experienced RASH (Rush size of a quarter, then had a size of half of a dollar, and now is two and a half inches). On an unknown date, the patient experienced PRURITUS (Itches and gets bigger), FEELING HOT (Warm to the touch) and ERYTHEMA (Red). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency. On 08-Feb-2021, PRURITUS (Itches and gets bigger), FEELING HOT (Warm to the touch), ERYTHEMA (Red) and RASH (Rush size of a quarter, then had a size of half of a dollar, and now is two and a half inches) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       The patient received their first dose and two days later, they experienced rash size of a quarter, then had a size of half of a dollar, and now was two and a half inches. The patient reported no pain but said that it was itching and was getting bigger and was red and warm to the touch.  On 15-Jul-2021, the patient reported that they began to experience reactions on 27-Jan-2021. The patient also reported that the final diagnosis for the reported reaction was hypersensitivity reaction and they received their second dose on 02-Mar-2021 and the batch number for the second dose was 0264z1a.   Most recent FOLLOW-UP information incorporated above includes: On 20-Apr-2021: Additional information was received. Updated the patient initials. On 15-Jul-2021: Follow-up information was received. Updated the patient demographics. Added Concomitant medications and Treatment medications.Updated the action taken. Updated the Outcome of the events as recovered. Added events stop date.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
eyes are hurting; bad headache; This spontaneous case was reported by a consumer and describes the occurrence of EYE PAIN (eyes are hurting) and HEADACHE (bad headache) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced EYE PAIN (eyes are hurting) and HEADACHE (bad headache). At the time of the report, EYE PAIN (eyes are hurting) and HEADACHE (bad headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided. Treatment information was not provided (but the patient asked if he could take paracetamol).
Information has been received from a lawyer regarding a case in litigation concerning a female patient (age unknown). The patient's medical history, concurrent conditions and concomitant medication use were not provided. In January 2013 the patient was inoculated with ZOSTAVAX, (lot # and route unknown) as recommended for routine adult health maintenance and for the prevention of shingles. The vaccine did not prevent shingles as intended and the patient subsequently contracted a persistent strain of herpes zoster. On or about 15-JUL-2016, the patient was treated by a physician for a persistent and severe vesicular rash, which was diagnosed as herpes zoster. The patient has been prescribed acyclovir and MEDROL for management of her painful symptoms and chronic pain. As a direct and proximate result of the ZOSTAVAX vaccine, and/or despite receiving ZOSTAVAX for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient as suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. Additional information has been requested.
Shortly after receiving the injection my arm went ice cold all the way to my fingers and warmed up again quickly. On the way home (about an hour later) I noticed numbness and tingling in my hand and that has continued since (11 days as of this report). My upper arm muscle was sore later that evening and by the next day the pain in my upper arm was extreme. I couldn't move my arm without extreme pain. I took some tylenol late in the day and that did help cut down on some of the pain. I also put an ice pack on my upper arm but it didn't help. The pain wasn't as bad the next (3rd) day but it's still significant enough for me to restrict activity with it. There is also a burning sensation off and on as well as itching deep in my arm. My upper arm has also felt like there is a tight band around it (since day 2) although the muscles themselves don't feel like there's any tightness or knots. I took ibuprofen on day 10 and it helped a little but not a whole lot. At this point I also have what feels like swelling or tenderness under my arm near the armpit area. The pain, burning and itching in my upper arm continues as well as the numbness, tingling and pins all up and down my arm to my hand and fingers.
First symptom occurred several hours after receiving shot, around 2 am. I woke up with pain in my upper stomach which lead to diarrhea. The diarrhea wasn't too bad but throughout the day I was feeling weak from not eating and the stomach pain came and went.  The next day around 2 pm, around 18 hrs after the flu shot, I felt hot and had a mild headache so I check my temperature and it was at 100.5. I took some Tylenol and a cold shower. Around this time I started feeling anxious and a bit paniced. I'm not sure if that's from the flu shot or my generalized anxiety disorder, but I wasn't feeling good so I took a lorazepam pill and went to sleep, around 7pm.  The next day I felt myself again and went through the whole day without a fever or any other symptom. Then around 6pm I experienced my body getting itchy. Upon further inspection I found red patches all over my body. It looked liked hives or an allergic reaction, so I took Benadryl and it went away after some time. The following day I was fine again, but I am noticing small areas with red patches, usually around my legs or hips. They seem to go away without taking any meds, but it is now 3 days with the red patches.
Fever 7 days later. A higher fever with muscle spasms another 8 days later. And fever with febrile seizure the next evening.
contracted covid after getting the vaccine; contracted covid after getting the vaccine; This is a spontaneous report from a Pfizer-sponsored program IBCC (Inbound Call Center for HCPs). A contactable physician reported similar events for 4 patients. This is 4th of 4 reports. A patient of unspecified age and gender received bnt162b2 (lot/batch number and expiration date not provided), via an unspecified route of administration, on an unspecified date, at single dose, for Covid-19 immunization. The patient medical history and concomitant medications were not reported. The patient contracted COVID after getting the vaccine. The outcome of the events was unknown.  Information on the lot/batch number has been requested.; Sender's Comments: The association between the event lack of effect (contracted COVID) with BNT162b2 can not be fully excluded.,Linked Report(s) : US-PFIZER INC-2021003873 same reporter/drug/event, different patient
This spontaneous report was received from a pharmacist and refers to a 69 year old female patient. The patient's concurrent conditions, medical history, concomitant medications and drug allergies were not reported. On 28-NOV-2018, the patient was vaccinated with PNEUMOVAX 23 (dose, strength, route of administration, lot # and expiry date were not reported) for prophylaxis. Other suspect therapy included unspecified flu shot. On 29-NOV-2018 (reported as one day after vaccination), the patient experienced a 2 to 3 inch raised, red band around the injection (reported as insertion) site. The patient did not notify her physician, did not seek any medical attention and did not received any treatment for adverse event. The event lasted 3 days and the outcome of it was reported as recovered on an approximately 01-DEC-2018. The causality between the event and the suspect therapies was not reported.